Pancreatic Beta-Cell Protection
Pancreatic Beta-Cell Protection market is segmented by players, region (country), by Type and by ... Read More
Global Urological Cancer Therapeutics Drugs Market Insights and Forecast to 2028
1 Study Coverage
1.1 Urological Cancer Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market by Application
1.3.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urological Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Urological Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Urological Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Urological Cancer Therapeutics Drugs Sales by Region
2.4.1 Global Urological Cancer Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Urological Cancer Therapeutics Drugs by Region (2023-2028)
2.5 Global Urological Cancer Therapeutics Drugs Revenue by Region
2.5.1 Global Urological Cancer Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Urological Cancer Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Urological Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Urological Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urological Cancer Therapeutics Drugs in 2021
3.2 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Urological Cancer Therapeutics Drugs Revenue in 2021
3.3 Global Urological Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Urological Cancer Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urological Cancer Therapeutics Drugs Sales by Type
4.1.1 Global Urological Cancer Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Urological Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Urological Cancer Therapeutics Drugs Revenue by Type
4.2.1 Global Urological Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Urological Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Urological Cancer Therapeutics Drugs Price by Type
4.3.1 Global Urological Cancer Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Urological Cancer Therapeutics Drugs Sales by Application
5.1.1 Global Urological Cancer Therapeutics Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Urological Cancer Therapeutics Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
5.2 Global Urological Cancer Therapeutics Drugs Revenue by Application
5.2.1 Global Urological Cancer Therapeutics Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Urological Cancer Therapeutics Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Urological Cancer Therapeutics Drugs Price by Application
5.3.1 Global Urological Cancer Therapeutics Drugs Price by Application (2017-2022)
5.3.2 Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Urological Cancer Therapeutics Drugs Market Size by Type
6.1.1 North America Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Urological Cancer Therapeutics Drugs Market Size by Application
6.2.1 North America Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
6.2.2 North America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
6.3 North America Urological Cancer Therapeutics Drugs Market Size by Country
6.3.1 North America Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Urological Cancer Therapeutics Drugs Market Size by Type
7.1.1 Europe Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Urological Cancer Therapeutics Drugs Market Size by Application
7.2.1 Europe Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
7.2.2 Europe Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
7.3 Europe Urological Cancer Therapeutics Drugs Market Size by Country
7.3.1 Europe Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Application
8.2.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Urological Cancer Therapeutics Drugs Market Size by Type
9.1.1 Latin America Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Urological Cancer Therapeutics Drugs Market Size by Application
9.2.1 Latin America Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
9.2.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
9.3 Latin America Urological Cancer Therapeutics Drugs Market Size by Country
9.3.1 Latin America Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Application
10.2.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Astellas
11.5.1 Astellas Corporation Information
11.5.2 Astellas Overview
11.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Astellas Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Astellas Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Corporation Information
11.8.2 Celgene Corporation Overview
11.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Celgene Corporation Recent Developments
11.9 Dendreon Corporation
11.9.1 Dendreon Corporation Corporation Information
11.9.2 Dendreon Corporation Overview
11.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dendreon Corporation Recent Developments
11.10 Ferring Pharmaceuticals
11.10.1 Ferring Pharmaceuticals Corporation Information
11.10.2 Ferring Pharmaceuticals Overview
11.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ferring Pharmaceuticals Recent Developments
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Corporation Information
11.11.2 GlaxoSmithKline plc Overview
11.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline plc Recent Developments
11.12 Indevus Pharmaceuticals Inc
11.12.1 Indevus Pharmaceuticals Inc Corporation Information
11.12.2 Indevus Pharmaceuticals Inc Overview
11.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Indevus Pharmaceuticals Inc Recent Developments
11.13 Ipsen
11.13.1 Ipsen Corporation Information
11.13.2 Ipsen Overview
11.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ipsen Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ipsen Recent Developments
11.14 Roche Healthcare
11.14.1 Roche Healthcare Corporation Information
11.14.2 Roche Healthcare Overview
11.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Roche Healthcare Recent Developments
11.15 Sanofi S.A.
11.15.1 Sanofi S.A. Corporation Information
11.15.2 Sanofi S.A. Overview
11.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sanofi S.A. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urological Cancer Therapeutics Drugs Industry Chain Analysis
12.2 Urological Cancer Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urological Cancer Therapeutics Drugs Production Mode & Process
12.4 Urological Cancer Therapeutics Drugs Sales and Marketing
12.4.1 Urological Cancer Therapeutics Drugs Sales Channels
12.4.2 Urological Cancer Therapeutics Drugs Distributors
12.5 Urological Cancer Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Urological Cancer Therapeutics Drugs Industry Trends
13.2 Urological Cancer Therapeutics Drugs Market Drivers
13.3 Urological Cancer Therapeutics Drugs Market Challenges
13.4 Urological Cancer Therapeutics Drugs Market Restraints
14 Key Findings in The Global Urological Cancer Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Xofigo (radium Ra 223 dichloride)
Table 3. Major Manufacturers of Jevtana (cabazitaxel)
Table 4. Major Manufacturers of Inlyta (axitinib)
Table 5. Major Manufacturers of Votrient (pazopanib hydrochloride)
Table 6. Major Manufacturers of Sutent (sunitinib malate)
Table 7. Major Manufacturers of Zytiga (abiraterone acetate)
Table 8. Major Manufacturers of Xtandi (enzalutamide)
Table 9. Major Manufacturers of Opdivo (nivolumab)
Table 10. Major Manufacturers of Provenge (sipuleucel-T)
Table 11. Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Urological Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Urological Cancer Therapeutics Drugs Sales by Region (2017-2022) & (K MT)
Table 14. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 15. Global Urological Cancer Therapeutics Drugs Sales by Region (2023-2028) & (K MT)
Table 16. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2023-2028)
Table 17. Global Urological Cancer Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 19. Global Urological Cancer Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 20. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2023-2028)
Table 21. Global Urological Cancer Therapeutics Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 22. Global Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2017-2022)
Table 23. Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 25. Urological Cancer Therapeutics Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 26. Global Urological Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2021)
Table 28. Urological Cancer Therapeutics Drugs Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Urological Cancer Therapeutics Drugs Product Offered
Table 30. Date of Manufacturers Enter into Urological Cancer Therapeutics Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 33. Global Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 34. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2017-2022)
Table 35. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2023-2028)
Table 36. Global Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 39. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2023-2028)
Table 40. Urological Cancer Therapeutics Drugs Price by Type (2017-2022) & (USD/MT)
Table 41. Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 42. Global Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 43. Global Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 44. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2017-2022)
Table 45. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2023-2028)
Table 46. Global Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 49. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2023-2028)
Table 50. Urological Cancer Therapeutics Drugs Price by Application (2017-2022) & (USD/MT)
Table 51. Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 52. North America Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 53. North America Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 54. North America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 57. North America Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 58. North America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Urological Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K MT)
Table 61. North America Urological Cancer Therapeutics Drugs Sales by Country (2023-2028) & (K MT)
Table 62. North America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Urological Cancer Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 65. Europe Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 66. Europe Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 69. Europe Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 70. Europe Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Urological Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K MT)
Table 73. Europe Urological Cancer Therapeutics Drugs Sales by Country (2023-2028) & (K MT)
Table 74. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 77. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 78. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 81. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 82. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2017-2022) & (K MT)
Table 85. Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2023-2028) & (K MT)
Table 86. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 89. Latin America Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 90. Latin America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 93. Latin America Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 94. Latin America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Urological Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K MT)
Table 97. Latin America Urological Cancer Therapeutics Drugs Sales by Country (2023-2028) & (K MT)
Table 98. Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Type (2017-2022) & (K MT)
Table 101. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Type (2023-2028) & (K MT)
Table 102. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Application (2017-2022) & (K MT)
Table 105. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Application (2023-2028) & (K MT)
Table 106. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2017-2022) & (K MT)
Table 109. Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2023-2028) & (K MT)
Table 110. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Novartis Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Pfizer Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Johnson & Johnson Corporation Information
Table 123. Johnson & Johnson Description and Major Businesses
Table 124. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Johnson & Johnson Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Johnson & Johnson Recent Developments
Table 127. AstraZeneca Corporation Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. AstraZeneca Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Astellas Corporation Information
Table 133. Astellas Description and Major Businesses
Table 134. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Astellas Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Astellas Recent Developments
Table 137. Bristol-Myers Squibb Corporation Information
Table 138. Bristol-Myers Squibb Description and Major Businesses
Table 139. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bristol-Myers Squibb Recent Developments
Table 142. Abbott Laboratories Corporation Information
Table 143. Abbott Laboratories Description and Major Businesses
Table 144. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Abbott Laboratories Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Abbott Laboratories Recent Developments
Table 147. Celgene Corporation Corporation Information
Table 148. Celgene Corporation Description and Major Businesses
Table 149. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. Celgene Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Celgene Corporation Recent Developments
Table 152. Dendreon Corporation Corporation Information
Table 153. Dendreon Corporation Description and Major Businesses
Table 154. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. Dendreon Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Dendreon Corporation Recent Developments
Table 157. Ferring Pharmaceuticals Corporation Information
Table 158. Ferring Pharmaceuticals Description and Major Businesses
Table 159. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Ferring Pharmaceuticals Recent Developments
Table 162. GlaxoSmithKline plc Corporation Information
Table 163. GlaxoSmithKline plc Description and Major Businesses
Table 164. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 165. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. GlaxoSmithKline plc Recent Developments
Table 167. Indevus Pharmaceuticals Inc Corporation Information
Table 168. Indevus Pharmaceuticals Inc Description and Major Businesses
Table 169. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 170. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Indevus Pharmaceuticals Inc Recent Developments
Table 172. Ipsen Corporation Information
Table 173. Ipsen Description and Major Businesses
Table 174. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 175. Ipsen Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Ipsen Recent Developments
Table 177. Roche Healthcare Corporation Information
Table 178. Roche Healthcare Description and Major Businesses
Table 179. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 180. Roche Healthcare Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Roche Healthcare Recent Developments
Table 182. Sanofi S.A. Corporation Information
Table 183. Sanofi S.A. Description and Major Businesses
Table 184. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 185. Sanofi S.A. Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Sanofi S.A. Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Urological Cancer Therapeutics Drugs Distributors List
Table 190. Urological Cancer Therapeutics Drugs Customers List
Table 191. Urological Cancer Therapeutics Drugs Market Trends
Table 192. Urological Cancer Therapeutics Drugs Market Drivers
Table 193. Urological Cancer Therapeutics Drugs Market Challenges
Table 194. Urological Cancer Therapeutics Drugs Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Product Picture
Figure 3. Global Urological Cancer Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Xofigo (radium Ra 223 dichloride) Product Picture
Figure 4. Jevtana (cabazitaxel) Product Picture
Figure 5. Inlyta (axitinib) Product Picture
Figure 6. Votrient (pazopanib hydrochloride) Product Picture
Figure 7. Sutent (sunitinib malate) Product Picture
Figure 8. Zytiga (abiraterone acetate) Product Picture
Figure 9. Xtandi (enzalutamide) Product Picture
Figure 10. Opdivo (nivolumab) Product Picture
Figure 11. Provenge (sipuleucel-T) Product Picture
Figure 12. Global Urological Cancer Therapeutics Drugs Market Share by Application in 2021 & 2028
Figure 13. Hospital
Figure 14. Medical Research Laboratory
Figure 15. Others
Figure 16. Urological Cancer Therapeutics Drugs Report Years Considered
Figure 17. Global Urological Cancer Therapeutics Drugs Sales 2017-2028 (K MT)
Figure 18. Global Urological Cancer Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Urological Cancer Therapeutics Drugs Revenue 2017-2028 (US$ Million)
Figure 20. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 22. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2023-2028)
Figure 23. North America Urological Cancer Therapeutics Drugs Sales YoY (2017-2028) & (K MT)
Figure 24. North America Urological Cancer Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Urological Cancer Therapeutics Drugs Sales YoY (2017-2028) & (K MT)
Figure 26. Europe Urological Cancer Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Urological Cancer Therapeutics Drugs Sales YoY (2017-2028) & (K MT)
Figure 28. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Urological Cancer Therapeutics Drugs Sales YoY (2017-2028) & (K MT)
Figure 30. Latin America Urological Cancer Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Urological Cancer Therapeutics Drugs Sales YoY (2017-2028) & (K MT)
Figure 32. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Urological Cancer Therapeutics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Urological Cancer Therapeutics Drugs in the World: Market Share by Urological Cancer Therapeutics Drugs Revenue in 2021
Figure 35. Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 39. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 40. North America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 42. North America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 43. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 44. North America Urological Cancer Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 45. North America Urological Cancer Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 46. U.S. Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 49. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 50. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 52. Europe Urological Cancer Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 53. Europe Urological Cancer Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 54. Germany Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. France Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Urological Cancer Therapeutics Drugs Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Urological Cancer Therapeutics Drugs Revenue Share by Region (2017-2028)
Figure 65. China Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. India Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 75. Latin America Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 77. Latin America Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Urological Cancer Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 79. Latin America Urological Cancer Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 80. Mexico Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Urological Cancer Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Urological Cancer Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 89. Turkey Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Urological Cancer Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Urological Cancer Therapeutics Drugs Value Chain
Figure 93. Urological Cancer Therapeutics Drugs Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Pfizer Johnson & Johnson AstraZeneca Astellas Bristol-Myers Squibb Abbott Laboratories Celgene Corporation Dendreon Corporation Ferring Pharmaceuticals GlaxoSmithKline plc Indevus Pharmaceuticals Inc Ipsen Roche Healthcare Sanofi S.A.